Navigation Links
Elsevier and the Neuroscience Information Framework Work Together to Improve Reporting of Research in Neuroscience Literature
Date:11/7/2013

AMSTERDAM, November 7, 2013 /PRNewswire/ --

Elsevier recommends authors to follow the Minimal Data Standards

Elsevier, a world-leading provider of scientific, technical and medical information products and services, announces its collaboration with the Neuroscience Information Framework (NIF), by incorporating the Minimal Data Standards across four of its neuroscience journals.

Minimal Data Standards are a set of recommendations developed by NIF, the most comprehensive portal of available web-based resources in the field of neuroscience, to facilitate resource identification in published neuroscience articles. One of the big challenges that neuroscientists face today is that research findings reported in the literature often lack sufficient details to enable reproducibility of methodology or reuse of data. With the launch of the Minimal Data Standards, NIF aims to address this issue.

Elsevier is one of the first scholarly publishers to adopt the Minimal Data Standards guidelines. Initially four Elsevier journals will take part in the pilot: Brain Research, Experimental Neurology, Journal of Neuroscience Methods, and Neurobiology of Disease. These journals will incorporate the guidelines into their article submission process, recommending authors to include gene/genome accession numbers, species specific nomenclatures, antibody identifiers, and software details in the methods section of their articles. More Elsevier neuroscience journals will join the initiative as the pilot further develops in 2014.

Prof. Maryann Martone, Professor of Neuroscience at the University of California San Diego, and Executive Director of the Future of Research Communications and e-Scholarship (FORCE11), said, "Scientific reproducibility starts with materials and methods. We are pleased to work with Elsevier to help neuroscientists make their methods more understandable for not only humans but also machines. This pilot is a step towards changing the way we write papers to take advantage of 21st century technology for searching and linking across vast amounts of information."

Michael Osuch, Publishing Director for Neuroscience & Psychology at Elsevier, said, "With our support for the Minimal Data Standards, we aim to make it easier for the community to identify the key resources used to produce the data in published studies. Neuroscience is a highly multi-disciplinary field with thousands of relevant web-based resources and data repositories. Direct linking to all of them would have been impossible without NIF's capacity to serve as a central portal."

Supporting the NIF to roll out the Minimal Data Standards pilot with the aim of developing better and more accurate resource identification within the neuroscience literature, falls within the scope of Article of the Future, Elsevier's on-going program to improve the format of the scientific article.

About the Neuroscience Information Framework

An initiative of the NIH Blueprint for Neuroscience Research, the Neuroscience Information Framework (NIF) advances neuroscience research by enabling discovery and access to public research data and tools worldwide through an open source, networked environment. In addition to giving access to over 200 neuroscience relevant databases and data sets, NIF hosts millions of annotations on the literature, which includes information about the reagents used in the paper, links to data, and comments about the data or arguments presented in the paper.

About Elsevier

Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.

A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions. The group employs more than 30,000 people, including more than 15,000 in North America. Reed Elsevier Group PLC is owned equally by two parent companies, Reed Elsevier PLC and Reed Elsevier NV. Their shares are traded on the London, Amsterdam and New York Stock Exchanges using the following ticker symbols: London: REL; Amsterdam: REN; New York: RUK and ENL.

Media contact
Shamus O'Reilly
Publisher Neuroscience
Elsevier
+44(0)1865-843651
s.oreilly@elsevier.com


'/>"/>
SOURCE Elsevier
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
2. Elsevier / MEDai Appoints Tom Zajac as New President
3. Elsevier Collaborates with the American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.)
4. Elsevier and Federation of Biochemical Societies Launch New Journal: FEBS Open Bio
5. Elsevier Foundation Awards 2011 Grants to Advance Women in Science and Support Libraries in Developing Countries
6. Elsevier Acquires QUOSA, Provider of Life Sciences Content Management and Workflow Productivity Solutions
7. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform: NursingChina.com
8. Leading German Researcher Awarded Elseviers 2011 Tetrahedron Prize
9. Elsevier/Gold Standard Exclusive Publisher of New Predictive Drug Price Type
10. Elsevier Collaborates With Prophecy Healthcare to Enhance Its Staff Development Offerings for Healthcare Organizations
11. Elsevier Launches New Journal: Learning, Culture and Social Interaction
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/5/2016)... , Feb. 5, 2016 Australian-US drug discovery and ... today the appointment of a new Chairman, Mr John ... , effective immediately. James Garner , has ... Director and former Acting CEO, Mr Iain Ross , ... Director. --> James Garner , has also been ...
(Date:2/4/2016)... , ... February 04, 2016 , ... ... GC-MS and triple quad LC-MS, host live demos and poster sessions, and present ... and exhibition. The conference takes place March 6 to 10 at the Georgia ...
(Date:2/4/2016)... VANCOUVER, British Columbia and MENLO PARK, ... Inc. (OTCQX: DMPI) ("DelMar" and the "Company"), a biopharmaceutical ... therapies, today announced that it will present at the ... on Monday, February 8, 2016 at 10:00 a.m. EST in ... Jeffrey Bacha , DelMar,s president and CEO, will provide an ...
(Date:2/4/2016)... 4, 2016 Sinovac Biotech Ltd. ("Sinovac" or ... of biopharmaceutical products in China , ... of directors received on February 4, 2016 a preliminary ... consortium comprised of PKU V-Ming ( Shanghai ... CICC Qianhai Development ( Shenzhen ) Fund ...
Breaking Biology Technology:
(Date:1/13/2016)... ALBANY, New York , January 13, 2016 /PRNewswire/ ... Transparency Market Research has published a new market report ... Share, Growth, Trends, and Forecast, 2015 - 2023. According to ... mn in 2014 and is anticipated to reach US$1,625.8 ... from 2015 to 2023. In terms of volume, the ...
(Date:1/11/2016)... , Jan. 11, 2016 Synaptics Incorporated (NASDAQ: ... solutions, today announced that its ClearPad ® TouchView ... products won two separate categories in the 8 th ... and Best Technology Breakthrough. The Synaptics ® TDDI ... simplified supply chain, thinner devices, brighter displays and borderless ...
(Date:1/8/2016)... MANCHESTER, United Kingdom , Jan. 8, 2016 /PRNewswire/ ... sensor-based diagnostic products, today announced the closing of a $9 ... investors.  Proceeds from the financing will be used to accelerate ... device for detecting early-stage pressure ulcers. ... after receiving CE Mark approval. The device,s introduction has been ...
Breaking Biology News(10 mins):